These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15460851)

  • 41. [Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions].
    Szucs TD; Lüscher TF; Gutzwiller F
    Schweiz Med Wochenschr; 1997 Nov; 127(44):1819-23. PubMed ID: 9446200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
    Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Simvastatin].
    Taéron C
    Rev Infirm; 2008 Jun; (141):47-9. PubMed ID: 18669392
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.
    Usher-Smith J; Ramsbottom T; Pearmain H; Kirby M
    Int J Clin Pract; 2008 Mar; 62(3):480-4. PubMed ID: 18201178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
    Roth EM; McKenney JM; Kelly MT; Setze CM; Carlson DM; Gold A; Stolzenbach JC; Williams LA; Jones PH
    Am J Cardiovasc Drugs; 2010; 10(3):175-86. PubMed ID: 20524719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 48. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Simvastatin after myocardial infarct. Losing no time].
    MMW Fortschr Med; 2001 Apr; 143(15):51. PubMed ID: 11349324
    [No Abstract]   [Full Text] [Related]  

  • 50. Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia.
    Ferro D; Basili S; Alessandri C; Mantovani B; Cordova C; Violi F
    Lancet; 1997 Oct; 350(9086):1222. PubMed ID: 9652566
    [No Abstract]   [Full Text] [Related]  

  • 51. Rhabdomyolysis due to interaction of simvastatin with mibefradil.
    Schmassmann-Suhijar D; Bullingham R; Gasser R; Schmutz J; Haefeli WE
    Lancet; 1998 Jun; 351(9120):1929-30. PubMed ID: 9654265
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy and safety of morning versus evening dose of controlled-release simvastatin tablets in patients with hyperlipidemia: a randomized, double-blind, multicenter phase III trial.
    Kim SH; Kim MK; Seo HS; Hyun MS; Han KR; Cho SW; Kim YK; Hoon Park S
    Clin Ther; 2013 Sep; 35(9):1350-60.e1. PubMed ID: 23998970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin therapy and small fibre neuropathy: a serial electrophysiological study.
    Lo YL; Leoh TH; Loh LM; Tan CE
    J Neurol Sci; 2003 Apr; 208(1-2):105-8. PubMed ID: 12639733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.
    Nakad A; Bataille L; Hamoir V; Sempoux C; Horsmans Y
    Lancet; 1999 May; 353(9166):1763-4. PubMed ID: 10347994
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypercholesterolaemia: Clarifications from adverse drug reactions agency.
    Cox A
    BMJ; 2008 Sep; 337():a1669. PubMed ID: 18796483
    [No Abstract]   [Full Text] [Related]  

  • 57. Interaction between simvastatin and L-thyroxine.
    Kisch E; Segall HS
    Ann Intern Med; 2005 Oct; 143(7):547. PubMed ID: 16204175
    [No Abstract]   [Full Text] [Related]  

  • 58. In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
    Med Lett Drugs Ther; 2012 Jan; 54(1381):4. PubMed ID: 22233589
    [No Abstract]   [Full Text] [Related]  

  • 59. Pravastatin: a potential cause for acute pancreatitis.
    Tsigrelis C; Pitchumoni CS
    World J Gastroenterol; 2006 Nov; 12(43):7055-7. PubMed ID: 17109506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin-disclosed acid maltase deficiency.
    Voermans NC; Lammens M; Wevers RA; Hermus AR; van Engelen BG
    J Intern Med; 2005 Aug; 258(2):196-7. PubMed ID: 16018797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.